Impaired NO bioavailability due to endothelial dysfunction and NADPH oxidase overexpression also directly contribute to vascular smooth muscle cell growth, proliferation, contraction, and differentiation, which are also major determinants of aneurysm development (21). The gene discussed is FMO5; the disease is aneurysm.